Volume 8, Issue 6, November 2020, Page: 101-109
FLASH Syndrome: Tapping into the Root of Chronic Illness
Michael Raymond Binder, North Shore University Health System, Highland Park Hospital, Highland Park, Illinois, USA
Received: Nov. 3, 2020;       Accepted: Nov. 13, 2020;       Published: Nov. 23, 2020
DOI: 10.11648/j.ajcem.20200806.11      View  97      Downloads  75
Abstract
It has now been established that persons with higher resting heart rates are at increased risk of morbidity and mortality from a plethora of mental and physical illnesses. However, the mechanism underlying the predictive value of this core vital sign remains obscure. This seminal report will integrate clinical, neuropsychological, physiological, and genetic evidence to assert that an inherent hyperexcitability of the neurological system is at the heart of the connection between resting heart rate and disease. Hypothetically, neuronal hyperexcitability can cause multiple circuits in the brain to overfire, including cognitive circuits, limbic circuits, and autonomic circuits, thereby dysregulating the associated systems of the body and allowing the aberration to be detected through standard vital signs and related measures of autonomic activity. Because the cognitive-emotional system is exquisitely sensitive to neuronal excitation, the aberration could also manifest as psychiatric symptomatology, thus suggesting that psychiatric symptoms may be the first subjective markers of the abnormality. Based on the well-recognized link between mental illness, autonomic dysregulation, and systemic disease together with mounting evidence that the related illnesses are associated with gene variants whose protein products fail to adequately regulate the firing of neurons, the vulnerability trait could aptly be called Familial Limbic Autonomic System Hyperexcitability or “FLASH.” Because the trait appears to be so common, its effects so pervasive, and its expression so modifiable, its identification is of critical importance to every medical specialty. FLASH could give clinicians the first comprehensive biological target through which to treat and prevent a plethora of mental, emotional, and physical illnesses.
Keywords
Prognostic Indicators, Heart Rate, Heart Rate Variability, Heart Rate Recovery, Respiratory Rate, Neuronal Hyperexcitability, Molecular Genetics, Ion Channelopathies
To cite this article
Michael Raymond Binder, FLASH Syndrome: Tapping into the Root of Chronic Illness, American Journal of Clinical and Experimental Medicine. Vol. 8, No. 6, 2020, pp. 101-109. doi: 10.11648/j.ajcem.20200806.11
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Colangelo LA, Yano Y, Jacobs Jr DR, Lloyd-Jones DM. Association of Resting Heart Rate With Blood Pressure and Incident Hypertension Over 30 Years in Black and White Adults: The CARDIA Study. Hypertension 2020; 76 (3): 692-698.
[2]
Shi Y, Zhou W, Liu S, et al. Resting heart rate and the risk of hypertension and heart failure: a dose-response meta-analysis of prospective studies. J Hypertens 2018; 36 (5): 995-1004.
[3]
Shen L, Wang Y, Jiang X, et al. Dose-response association of resting heart rate and hypertension in adults: A systematic review and meta-analysis of cohort studies. Medicine (Baltimore) 2020; 99 (10): e19401.
[4]
Dalal J, Dasbiswas A, Sathyamurthy I, et al. Heart Rate in Hypertension: Review and Expert Opinion. International Journal of Hypertension 2019; 2019.
[5]
Lee DH, de Rezende LFM, Hu FB, Jeon JY, Giovannucci EL. Resting heart rate and risk of type 2 diabetes: a prospective cohort study and meta-analysis. Diabetes Metab Res Rev 2019; 35 (2): e3095.
[6]
Aune D, o’Hartaigh B, Vatten LJ. Resting heart rate and the risk of type 2 diabetes: A systematic review and dose-response meta-analysis of cohort studies. Nutr Metab Cardiovasc Dis 2015; 25 (6): 526-534.
[7]
Nagaya T, Yoshida H, Takahashi H, Kawai M. Resting heart rate and blood pressure, independent of each other, proportionally raise the risk for type-2 diabetes mellitus. Int J Epidemiol 2010; 39 (1): 215-222.
[8]
Kannel W, Kannel C, Paffenbarger R, Cupples A. Heart rate and cardiovascular mortality: The Framingham study. Am Heart J 1987; 113: 1489-1494.
[9]
Gillum R, Makuc D, Feldman J. Pulse rate, coronary heart disease, and death: The NHANES I epidemiologic follow-up study. Am Heart J 1991; 121: 172-177.
[10]
Cooney MT, Vartiainen E, Laatikainen T, et al. Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women. Am Heart J 2010; 159 (4): 612-619.
[11]
Khan H, Kunutsor S, Kalogeropoulos AP, et al. Resting heart rate and risk of incident heart failure: three prospective cohort studies and a systematic meta-analysis. J Am Heart Assoc 2015; 4 (1): e001364.
[12]
Alhalabi L, Singleton MJ, Oseni AO, et al. Relation of higher resting heart rate to risk of cardiovascular versus noncardiovascular death. Am J Cardiol 2017; 119 (7): 1003-1007.
[13]
Zhang D, Shen X, Qi X. Resting heart rate and all-cause and cardiovascular mortality in the general population: a meta-analysis. CMAJ 2016; 188 (3): E53-E63.
[14]
Yu J, Dai L, Zhao Q. Association of cumulative exposure to resting heart rate with risk of stroke in general population: The Kailuan Cohort Study. Journal of Stroke and Cardiovascular Diseases 2017; (26): 11: 2501-2509.
[15]
Huang Y-Q, Shen G, Huang J-Y, Zhang B, Feng Y-Q. A nonlinear association between resting heart rate and ischemic stroke among community elderly hypertensive patients. Postgrad Med 2020; 132 (2): 215-219.
[16]
Aune D, Sen A, o’Hartaigh B, et al. Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality - A systematic review and dose-response meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis 2017; 27 (6): 504-517.
[17]
Eriksen BO, Småbrekke S, Jenssen TG, et al. Office and ambulatory heart rate as predictors of age-related kidney function decline: A population-based cohort study. Hypertension 2018; 72 (3): 594-601.
[18]
Anker MS, Ebner N, Hildebrandt B, et al. Resting heart rate is an independent predictor of death in patients with colorectal, pancreatic, and non-small cell lung cancer: results of a prospective cardiovascular long-term study. European Journal of Heart Failure 2016; 18 (12).
[19]
Park J, Kim JH, Park Y. Resting heart rate is an independent predictor of advanced colorectal adenoma recurrence. PLoS One 2018; 13 (3): e0193753.
[20]
Burke SL. Resting heart rate moderates the relationship between neuropsychiatric symptoms, MCI, and Alzheimer’s disease. Innov Aging 2019; 3 (suppl 1): S641.
[21]
Jouven X, Empana J-P, Schwartz PJ, et al. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 2005; 352: 1951-1958.
[22]
Latvala A, Kuja-Halkola R, Rick C, et al. Association of resting heart rate and blood pressure in late adolescence with subsequent mental disorders: A longitudinal population study of more than 1 million men in Sweden. JAMA Psychiatry 2016; 73 (12): 1268-1275.
[23]
Kemp AH, Brunoni AR, Santos IS, et al. Effects of depression, anxiety, comorbidity, and antidepressants on resting-state heart rate and its variability: an ELSA-Brasil cohort baseline study. Am J Psychiatry 2014; 171 (12): 1328-1334.
[24]
Cicek Y, Durakoglugil ME, Kocaman SA, et al. Increased pulse wave velocity in patients with panic disorder: independent vascular influence of panic disorder on arterial stiffness. J Psychosom Res 2012; 73 (2): 145-148.
[25]
Paulus EJ, Argo TR, Egge JA. The impact of posttraumatic stress disorder on blood pressure and heart rate in a veteran population. J Trauma Stress 2013; 26 (1): 169-172.
[26]
Pole N. The psychophysiology of posttraumatic stress disorder: a meta-analysis. Psychol Bull 2007; 133 (5): 725-746.
[27]
Alvares GA, Quintana DS, Hickie IB, Guastella AJ. Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medications: a systematic review and meta-analysis. J Psychiatry Neurosci 2016; 41 (2): 89-104.
[28]
Carney RM, Freedland KE, Veith RC. Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med 2005; 67 (suppl 1): S29-S33.
[29]
Clamor A, Lincoln TM, Thayer JF, Koenig J. Resting vagal activity in schizophrenia: meta-analysis of heart rate variability as a potential endophenotype. Br J Psychiatry 2016; 208 (1): 9-16.
[30]
Erlangsen A, Andersen PK, Toender A, et al. Cause-specific life-years lost in people with mental disorders: a nationwide, register-based cohort study. The Lancet 2017; DOI: 10.1016/s2215-0366 (17)30429-7.
[31]
Baumert M, Linz D, Stone K, et al. Mean nocturnal respiratory rate predicts cardiovascular and all-cause mortality in community-dwelling older men and women. European Respiratory Journal 2019; DOI: 10.1183/13993003.02175-2018.
[32]
Eick C, Groga-Bada P, Reinhardt K, et al. Nocturnal respiratory rate as a predictor of mortality in patients with acute coronary syndrome. Openheart 2018; 5 (2).
[33]
Dommasch M, Sinnecker D, Barthel P, et al. Nocturnal respiratory rate predicts non-sudden cardiac death in survivors of acute myocardial infarction. J Am Coll Cardiol 2014; 63: 2432-2433.
[34]
Yano Y, Kario K. Nocturnal blood pressure and cardiovascular disease: a review of recent advances. Hypertension Research 2012; 35: 695-701.
[35]
Gottesman RF, Schneider ALC, Albert M. Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study. JAMA Neurol 2014; 71 (10): 1218-1227.
[36]
Barletta G-M, Flynn J, [...], Furth S, et al. Heart rate and blood pressure variability in children with chronic kidney disease: a report from the CKiD study. Pediatr Nephral 2014; 29 (6): 1059-1065.
[37]
Tsuji H, Larson MG, Venditti FJ, et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996; 94: 2850–2855.
[38]
Thanou A, Stavrakis S, Dyer JW, et al. Impact of heart rate variability, a marker for cardiac health, on lupus disease activity. Arthritis Res Ther 2016; 18 (1): 197.
[39]
Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS. Heart rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 1999; 341: 1351-1357.
[40]
Ó Hartaigh B, Gill TM, [...], Hardy R, et al. Association between resting heart rate across the life course and all-cause mortality: longitudinal findings from the Medical Research Council (MRC) National Survey of Health and Development (NSHD). J Epidemiol Community Health 2014; 68 (9): 883-889.
[41]
Sanchez-Conde P, Beltran-Velasco AI, Clemente-Suarez VJ. Influence of psychological profile in autonomic response of nursing students in their first hospital clinical stays. Physiology & Behavior 2019; 207: 99-103.
[42]
McEwen BA. Stress, adaptation, and disease allostasis and allostatic load. Annals of the New York Academy of Sciences 1998; 840 (1): 33-44.
[43]
Larsen BA, Christenfeld NJS. Cardiovascular disease and psychiatric comorbidity: the potential role of preservative cognition. Cardiovascular Psychiatry and Neurology 2009; Article ID: 791017.
[44]
Blom EH, Serlachius E, Chesney MA, Olsson EMG. Adolescent girls with emotional disorders have a lower end-tidal CO2 and increased respiratory rate compared with healthy controls. Psychophysiology 2014; 51 (5): 412-418.
[45]
Binder MR. The multi-circuit neuronal hyperexcitability hypothesis of psychiatric disorders. AJCEM 2019; 7 (1): 12-30.
[46]
Yizhar O, Fenno LE, Prigge M, et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 2011; 477: 171-178.
[47]
Binder MR. Electrophysiology of seizure disorders may hold key to the pathophysiology of psychiatric disorders. AJCEM 2019; 7 (5): 103-110.
[48]
Takarae Y, Sweeney J. Neural hyperexcitability in autism spectrum disorders. Brain Sciences 2017; 7 (129).
[49]
Narkiewicz K, van de Borne P, Montano N, et al. Sympathetic neural outflow and chemoreflex sensitivity are related to spontaneous breathing rate in normal men. Hypertension 2005; 47 (1): 51-55.
[50]
Bradly AJ, Dinan TG. A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality. J Psychopharmacol 2010; 24 (4) 91-118.
[51]
Bahremand A, Ziai P, Khodadad TK, et al. Agmatine enhances the anticonvulsant effect of lithium chloride on pentylenetetrazole-induced seizures in mice: Involvement of L-arginine/nitric oxide pathway. Epilepsy & Behavior 2010; 18 (3): 186-192.
[52]
Brown P, Kashiviswanath S, Huynh A, et al. Lithium therapy in comorbid temporal lobe epilepsy and cycloid psychosis. Oxf Med Case Reports 2016; (12): omw089.
[53]
Shukla S, Mukherjee S, Decina P. Lithium in the treatment of bipolar disorders associated with epilepsy: an open study. J Clin Psychopharmacol 1988; 8 (3): 201-204.
[54]
Szabo ST, Blier P. Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons. Brain Research 2001; 922 (1): 9-20.
[55]
Khedr EM, Elserogy Y, Fawzy M. Effect of psychotropic drugs on cortical excitability of patients with major depressive disorders: A transcranial magnetic stimulation study. Psychiatry Research 2020; 291: 113287.
[56]
Ressler KJ, Mayberg HS. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci 2007; 10 (9): 1116-1124.
[57]
El-Mallakh RS, Vöhringer PA, Ostacher MM, et al. Antidepressants worsen rapid-cycling course in bipolar depression: A STEP-BD randomized clinical trial. Journal of Affective Disorders 2015; 184: 318-321.
[58]
Goldberg JF, Truman CJ. Antidepressant-induced mania: an overview of current controversies. Bipolar Disorders 2001; 5 (6).
[59]
Truman CJ, Goldberg JF, Ghaemi SN. Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry 2007; 68 (10): 1472-1479.
[60]
Henry C, Sorbara F, Lacoste J, Gindre C, Leboyer M. Antidepressant-induced mania in bipolar patients: Identification of risk factors. J Clin Psychiatry 2001; 62 (4): 249-255.
[61]
Yamaguchi Y, Kimoto S, Nagahama T, Kishimoto T. Dosage-related nature of escitalopram treatment-emergent mania/hypomania: a case series. Neuropsychiatr Dis Treat 2018; 14: 2099-2104.
[62]
Licht CM, de Geus EJ, van Dyck R, Penninx BW. Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability. Biol Psychiatry2010; 68 (9): 861-868.
[63]
Dawood T, Lambert EA, Barton DA, et al. Specific serotonin reuptake inhibition in major depressive disorder adversely affects novel markers of cardiac risk. Hypertens Res 2007; 30 (4): 285-293.
[64]
Kim HJ, Yang J, Lee M-S. Changes of heart rate variability during methylphenidate treatment in attention-deficit hyperactivity disorder children: A 12-week prospective study. Yonsei Med J 2015; 56 (5): 1365-1371.
[65]
Koschke M, Boettger MK, Schulz S, et al. Autonomy of autonomic dysfunction in major depression. Psychosom Med 2009; 71 (8): 852-860.
[66]
Udupa K, Thirthalli J, Sathyaprabha TN, et al. Differential actions of antidepressant treatments on cardiac autonomic alterations in depression: A prospective comparison. Asian Journal of Psychiatry 2011; 4: 100-106.
[67]
Yeragani VK, Roose S, Mallavarapu M, Radhakrishna RK, Pesce V. Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on measures of nonlinearity and chaos of heart rate. Neuropsychobiology 2002; 46: 125-135.
[68]
Van Zyl LT, Hazegawa T, Nagata K. Effects of antidepressant treatment on heart rate variability in major depression: A quantitative review. BioPsychSocial Medicine 2008; (2) 12.
[69]
Kemp AH, Quintana DS, Quinn CR, Hopkinson P, Harris AW. Major depressive disorder with melancholia displays robust alterations in resting state heart rate and its variability: implications for future morbidity and mortality. Front Psychol 2014; 5: 1387.
[70]
Herr RM, Barrech A, Reidel N, et al. Long-term effectiveness of stress management at work: Effects of the changes in perceived stress reactivity on mental health and sleep problems seven years later. Int J Environ Res Public Health 2018; 15 (2): 255.
[71]
Brainstorm Consortium; Anttila V, Bulik-Sullivan B, Finucane HK, et al. Analysis of shared heritability in common disorders of the brain. Science 2018; 360 (6395): eaap8757.
[72]
Beissner F, Meissner K, Bär KJ, Napadow V. The autonomic brain: an activation likelihood estimation meta-analysis for central processing of autonomic function. J Neurosci 2013; 33 (25): 10503-10511.
[73]
Keyes KM, Eaton NR, Hasin DS. Childhood maltreatment and the structure of common psychiatric disorders. British Journal of Psychiatry 2012; 200 (2): 107-115.
[74]
Uher R, Zwicker A. Etiology in psychiatry: embracing the reality of poly-gene-environmental causation of mental illness. World Psychiatry 2017; 16 (2).
[75]
Rosenman RH, Brand RJ, Sholtz RI, Friedman M. Multivariate prediction of coronary heart disease during 8.5 year follow-up in the Western Collaborative Group study. The American Journal of Cardiology 1976; 37 (6): 903-910.
[76]
Kupper N, Donollet J. Type D personality as a risk factor in coronary heart disease: a review of current evidence. Curr Cardiol Rep 2018; 20 (11): 104.
[77]
Ferreira, MAR, O’Donovan MC, [...], Sklar P. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008; 40 (9): 1056-1058.
[78]
Lopez AY, Wang X, Xu M, et al. Ankyrin-G isoform imbalance and interneuronopathy link epilepsy and bipolar disorder. Mol Psychiatry 2017; 22 (10): 1464–1472.
[79]
Green EK, Grozeva D, Jones I, et al., Wellcome Trust Case Control Consortium, Holmans, PA, Owen, MJ, O'Donovan, MC, Craddock N. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry 2010; 15 (10): 1016-1022.
[80]
Liu Y, Blackwood DH, Caesar S, et al. Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol Psychiatry 2011; 16 (1).
[81]
Iqbal Z, Vandeweyer G, van der Voet M, et al. Homozygous and heterozygous disruptions of ANK3: at the crossroads of neurodevelopmental and psychiatric disorders. Human Molecular Genetics 2013; 22: 1960-1970.
[82]
Santos M, D'Amico D, Spadoni O, et al. Hippocampal hyperexcitability underlies enhanced fear memories in TgNTRK3, a panic disorder mouse model. Journal of Neuroscience 2013; 33 (38): 15259-15271.
[83]
Contractor A, Klyachko VA, Portera-Cailliau C. Altered neuronal and circuit excitability in Fragile X syndrome. Neuron 2015; 87 (4): 699-715.
[84]
O’Brien NL, Way MJ, Kandaswamy R, et al. The functional GRM3 Kozak sequence variant rs148754219 affects the risk of schizophrenia and alcohol dependence as well as bipolar disorder. Psychiatric Genetics 2014; 24: 277–278.
[85]
Schizophrenia Working Group of the Psychiatric Genomics Consortium: Ripke S, Neale BM, [...], O’Donovan MC. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511 (7510): 421-427.
[86]
Freedman R, Coon H, Myles-Worsley M, et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. PNAS 1997; 94 (2): 587–592.
[87]
Andrade A, Brennecke A, Mallat S, et al. Genetic associations between voltage-gated calcium channels and psychiatric disorders. Int J Mol Sci 2019; 20 (14): 3537.
[88]
Kim J-B. Channelopathies. Korean J of Pediatr 2014; 57 (1): 1-18.
[89]
Brunklaus A, Ellis R, Reavey E, Semsarian C, Zuberi SM. Genotype phenotype associations across the voltage-gated sodium channel family. J Med Genet 2014; 51 (10): 650-658.
[90]
D’Agnelli S, Arendt-Nielsen L, Gerra MC, et al. Fibromyalgia: Genetics and epigenetics insights may provide the basis for the development of diagnostic biomarkers. Molecular Pain 2019; 15.
[91]
Van de Borne P, Montano N, Zimmerman B, Pagani M, Somers VK. Relationship between repeated measures of hemodynamics, muscle sympathetic nerve activity, and their spectral oscillations. Circulation 1997; 96: 4326-4332.
[92]
Grunze HCR. The effectiveness of anticonvulsants in psychiatric disorders. Dialogues Clin Neurosci 2008; 10 (1): 77-89.
[93]
Binder MR. Introducing the term “Neuroregulator” in Psychiatry. AJCEM 2019; 7 (3): 66-70.
[94]
Hallioglu O, Okuyaz C, Mert E, Makharoblidze K. Effects of antiepileptic drug therapy on heart rate variability in children with epilepsy. Epilepsy Res 2008; 79 (1): 49-54.
Browse journals by subject